Bone marrow-derived progenitor cells in end-stage lung disease patients

BMC Pulmonary Medicine

Volumn 13, Issue 1, 2013, Pages

  Gilpin, Sarah E ^a   Lung, Kalvin ^a   de Couto, Geoffrey T ^b   Cypel, Marcelo ^a   Sato, Masaaki ^a   Singer, Lianne G ^a   Keshavjee, Shaf ^a   Waddell, Thomas K ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Clara cell; Fibrocytes; Lung progenitor; Migration

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CLARA CELL PROTEIN; COLLAGEN TYPE 1; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GENOMIC DNA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; STROMAL CELL DERIVED FACTOR 1;

ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS; CELL MIGRATION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; IN VITRO STUDY; LEUKOCYTE COUNT; LUNG DISEASE; LUNG FIBROSIS; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ADULT; BONE MARROW CELLS; BRONCHIOLITIS OBLITERANS; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CHEMOKINE CXCL12; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY FIBROSIS; STEM CELL FACTOR; STEM CELLS; UTEROGLOBIN;

EID: 84880901822     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-13-48     Document Type: Article

References (24)

1. de Perrot M, Chaparro C, McRae K, Waddell TK, Hadjiliadis D, Singer LG, Pierre AF, Hutcheon M, Keshavjee S. Twenty-year experience of lung transplantation at a single center: influence of recipient diagnosis on long-term survival. J Thorac Cardiovasc Surg 2004, 127(5):1493-1501. 10.1016/j.jtcvs.2003.11.047, 15116013.
2. Fraire AT. Inflammation. Molecular pathology of lung diseases 2008, 459-470. New York, NY: Springer, Zander DSP, Jagirdar H, Haque J, Barrios AR.
3. Brody SL, Atkinson JJ, Brody SL, Atkinson JJ. Epithelial repair and regeneration. Molecular pathology of lung diseases 2008, 476-490. New York, NY: Springer, Zander DSP, Jagirdar H, Haque J, Barrios AR.
4. Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J, Brigham KL. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005, 33(2):145-152. 10.1165/rcmb.2004-0330OC, 2715309, 15891110.
5. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, Phinney DG. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 2003, 100(14):8407-8411. 10.1073/pnas.1432929100, 166242, 12815096.
6. Mei SH, Haitsma JJ, Dos Santos CC, Deng Y, Lai PF, Slutsky AS, Liles WC, Stewart DJ. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med 2010, 182(8):1047-1057. 10.1164/rccm.201001-0010OC, 20558630.
7. Wagers AJ, Sherwood RI, Christensen JL, Weissman IL. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 2002, 297(5590):2256-2259. 10.1126/science.1074807, 12215650.
8. Wong AP, Keating A, Lu WY, Duchesneau P, Wang X, Sacher A, Hu J, Waddell TK. Identification of a bone marrow-derived epithelial-like population capable of repopulating injured mouse airway epithelium. J Clin Invest 2009, 119(2):336-348. 2631300, 19164856.
9. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, Belperio JA, Keane MP, Strieter RM. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004, 114(3):438-446. 484979, 15286810.
10. Moeller A, Gilpin SE, Ask K, Cox G, Cook D, Gauldie J, Margetts PJ, Farkas L, Dobranowski J, Boylan C, et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009, 179(7):588-594. 10.1164/rccm.200810-1534OC, 19151190.
11. Gilpin SE, Lung KC, Sato M, Singer LG, Keshavjee S, Waddell TK. Altered progenitor cell and cytokine profiles in bronchiolitis obliterans syndrome. J Heart Lung Transplant 2012, 31(2):222-228. 10.1016/j.healun.2011.11.012, 22305385.
12. Leigh MW, Kylander JE, Yankaskas JR, Boucher RC. Cell proliferation in bronchial epithelium and submucosal glands of cystic fibrosis patients. Am J Respir Cell Mol Biol 1995, 12(6):605-612. 10.1165/ajrcmb.12.6.7766425, 7766425.
13. Hajj R, Lesimple P, Nawrocki-Raby B, Birembaut P, Puchelle E, Coraux C. Human airway surface epithelial regeneration is delayed and abnormal in cystic fibrosis. J Pathol 2007, 211(3):340-350. 10.1002/path.2118, 17186573.
14. Lapar DJ, Burdick MD, Emaminia A, Harris DA, Strieter BA, Liu L, Robbins M, Kron IL, Strieter RM, Lau CL. Circulating fibrocytes correlate with bronchiolitis obliterans syndrome development after lung transplantation: a novel clinical biomarker. Ann Thorac Surg 2011, 92(2):470-477. 10.1016/j.athoracsur.2011.04.065, 3169386, 21801908.
15. Ito C, Sato H, Ando K, Watanabe S, Yoshiba F, Kishi K, Furuya A, Shitara K, Sugimoto S, Kohno H, et al. Serum stem cell growth factor for monitoring hematopoietic recovery following stem cell transplantation. Bone Marrow Transplant 2003, 32(4):391-398. 10.1038/sj.bmt.1704152, 12900775.
16. Moore BB, Kolodsick JE, Thannickal VJ, Cooke K, Moore TA, Hogaboam C, Wilke CA, Toews GB. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 2005, 166(3):675-684. 10.1016/S0002-9440(10)62289-4, 1780139, 15743780.
17. Gomperts BN, Strieter RM. Fibrocytes in lung disease. J Leukoc Biol 2007, 82:449-456. 10.1189/jlb.0906587, 17550974.
18. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001, 166(12):7556-7562.
19. Petty JM, Sueblinvong V, Lenox CC, Jones CC, Cosgrove GP, Cool CD, Rai PR, Brown KK, Weiss DJ, Poynter ME, et al. Pulmonary stromal-derived factor-1 expression and effect on neutrophil recruitment during acute lung injury. J Immunol 2007, 178(12):8148-8157.
20. Hiraoka A, Sugimura A, Seki T, Nagasawa T, Ohta N, Shimonishi M, Hagiya M, Shimizu S. Cloning, expression, and characterization of a cDNA encoding a novel human growth factor for primitive hematopoietic progenitor cells. Proc Natl Acad Sci USA 1997, 94(14):7577-7582. 10.1073/pnas.94.14.7577, 23864, 9207134.
21. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, Dewor M, Georgiev I, Schober A, Leng L, et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 2007, 13(5):587-596. 10.1038/nm1567, 17435771.
22. Schwartz V, Lue H, Kraemer S, Korbiel J, Krohn R, Ohl K, Bucala R, Weber C, Bernhagen J. A functional heteromeric MIF receptor formed by CD74 and CXCR4. FEBS Lett 2009, 583(17):2749-2757. 10.1016/j.febslet.2009.07.058, 2911026, 19665027.
23. Arndt U, Wennemuth G, Barth P, Nain M, Al-Abed Y, Meinhardt A, Gemsa D, Bacher M. Release of macrophage migration inhibitory factor and CXCL8/interleukin-8 from lung epithelial cells rendered necrotic by influenza A virus infection. J Virol 2002, 76(18):9298-9306. 10.1128/JVI.76.18.9298-9306.2002, 136427, 12186913.
24. Donnelly SC, Haslett C, Reid PT, Grant IS, Wallace WA, Metz CN, Bruce LJ, Bucala R. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 1997, 3(3):320-323. 10.1038/nm0397-320, 9055860.